Chemicals
MSPEA-backed Tianhe drops on resumption of trading
Morgan Stanley Private Equity Asia (MSPEA) portfolio company Tianhe Chemicals saw its stock drop 43% on resumption of trading in Hong Kong following allegations of fraud. Tianhe issued a lengthy rebuttal of the allegations, while simultaneously announcing...
Permira in talks to sell Arysta to Platform Specialty – report
Arysta LifeScience, the Japanese agricultural chemicals maker owned by Permira that last month filed for a US IPO, is said to be in talks with Platform Specialty Products over a potential acquisition.
Aggressive demand for aggressive chemicals
Tankers used to ship chemicals require a degree of customization. Smaller than normal tankers, they are divided into self-contained compartments so that cargoes can be loaded without any mixing. There may also be specialized heating systems to keep chemicals...
Tianhe denies fraud allegations, MSPEA offers full support
Tianhe Chemicals has issued a point-by-point rebuttal of allegations that it made false statements in its IPO prospectus, with second-largest investor Morgan Stanley Private Equity Asia (MSPEA) declaring its full support.
SCPE, Tiger Group invest $95m in chemical tanking venture
Standard Chartered Private Equity (SCPE) and specialist maritime investor Tiger Group Investments have agreed to commit $95 million to Greathorse Chemical, which owns and operates a fleet of chemical tanker vessels.
Warburg Pincus, Baosteel in $488m industrial gases deal
Warburg Pincus and a subsidiary of Chinese steel producer Shanghai Baosteel Group have agreed to buy industrial gas assets from Henan Jinkai Chemical Investment Holding for RMB3 billion ($488 million).
PE-backed Tianhe sees marginal gain after $658m HK IPO
Tianhe Chemicals Group saw its stock gain up to 5% during the first morning of trading in Hong Kong. The company, which is backed by Morgan Stanley Private Equity Asia (MSPEA) and PAG, raised HK$5.1 billion ($658 million).
MSPEA-backed Tianhe targets $818m Hong Kong IPO
Tianhe Chemicals Group, a Chinese specialty chemicals maker backed by Morgan Stanley Private Equity Asia (MSPEA), is seeking to raise up to $818 million through a Hong Kong IPO.
Advent adds operating partners for China chemicals sector
Advent International has made the first additions to its global operating partner program in China, with Michael Ming-Yue Zhu and William Tsao recruited to advise on investment opportunities in the chemicals sector.
India's Hikal raises $8m debt from IFC
Indian chemical company Hikal, part of the Kalyani Group, will receive $8 million in debt financing International Financial Corporation (IFC).
ePlanet exits agro-chemicals firm as Japan's SDS enters
ePlanet will exit Indian agro-chemicals firm Sree Ramcides Chemicals as Japan's SDS Biotech invests INR1 billion ($18.8 million) in the company for a 65% stake.
IFC exits India's Kanoria Chemicals
International Finance Corporation (IFC), the World Bank's private investment arm, has sold its 10.88% stake in India’s Kanoria Chemicals, exiting at a small profit.
CNEI leads $23m investment in China Dadi Chemical
China New Enterprise Investment (CNEI) has led a $23 million round of funding for China Dadi Chemical, a leading industrial salt and salt chemicals producer. Korea Development Bank was a co-investor in the deal.
Asia Awards: PE Deal of the Year – Tianhe Chemicals
Morgan Stanley Private Equity Asia had to overcome trust issues and intense competition to secure its $300 million investment in Tianhe Chemicals. Chief Investment Officer Homer Sun explains how it happened
Carlyle exits Sinorgchem to China’s Sinochem
The Carlyle Group has exited its holding in rubber additives producer Jiangsu Sinorgchem Technology through a trade sale to Sinochem International, the overseas arm of the Chinese state-owned chemicals company. This is one of a series of transactions...
Bain sells JV interest in two Chinese chemicals companies
Bain Capital has exited its stake in Chinese companies Hipro Polymers and Casda Biomaterials to Arkema, France’s leading chemicals producer. The acquisition, which puts an enterprise value of $365 million on both companies, is subject to Chinese regulatory...